James W. Frane

2.5k total citations
51 papers, 1.9k citations indexed

About

James W. Frane is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, James W. Frane has authored 51 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in James W. Frane's work include Growth Hormone and Insulin-like Growth Factors (22 papers), Sexual Differentiation and Disorders (11 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (8 papers). James W. Frane is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (22 papers), Sexual Differentiation and Disorders (11 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (8 papers). James W. Frane collaborates with scholars based in United States, United Kingdom and Italy. James W. Frane's co-authors include Barbara M. Lippe, Steven D. Chernausek, Ron G. Rosenfeld, Joyce Kuntze, Kenneth M. Attie, Ann J. Johanson, Philippe Backeljauw, Raymond L. Hintz, José Cara and Barry M. Sherman and has published in prestigious journals such as Journal of the American Statistical Association, The Journal of Clinical Endocrinology & Metabolism and Technometrics.

In The Last Decade

James W. Frane

50 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James W. Frane United States	22	900	735	688	300	197	51	1.9k
Brenda Crowe United States	20	957 1.1×	616 0.8×	648 0.9×	278 0.9×	259 1.3×	33	1.8k
P.A.H. van Noord Netherlands	23	477 0.5×	445 0.6×	311 0.5×	219 0.7×	117 0.6×	36	1.9k
Karen O. Klein United States	32	1.1k 1.2×	1.2k 1.7×	1.5k 2.2×	393 1.3×	170 0.9×	81	4.0k
Bernet Kato United Kingdom	27	204 0.2×	935 1.3×	401 0.6×	184 0.6×	221 1.1×	49	2.9k
Robin N. Beaumont United Kingdom	24	252 0.3×	328 0.4×	951 1.4×	245 0.8×	128 0.6×	57	2.0k
Reedik Mägi Estonia	33	211 0.2×	1.4k 1.9×	2.0k 2.9×	268 0.9×	152 0.8×	107	3.9k
Hanieh Yaghootkar United Kingdom	20	242 0.3×	493 0.7×	593 0.9×	184 0.6×	175 0.9×	54	1.8k
I. Persson Sweden	26	618 0.7×	516 0.7×	822 1.2×	94 0.3×	63 0.3×	51	2.8k
Huub Straatman Netherlands	31	77 0.1×	460 0.6×	553 0.8×	451 1.5×	147 0.7×	77	3.1k
Samantha Welsh United Kingdom	2	277 0.3×	1.2k 1.6×	2.2k 3.2×	218 0.7×	368 1.9×	5	4.5k

Countries citing papers authored by James W. Frane

Since Specialization

Citations

This map shows the geographic impact of James W. Frane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Frane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Frane more than expected).

Fields of papers citing papers by James W. Frane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Frane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Frane. The network helps show where James W. Frane may publish in the future.

Co-authorship network of co-authors of James W. Frane

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Frane. A scholar is included among the top collaborators of James W. Frane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Frane. James W. Frane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bharucha, Kamal, Hermine I. Brunner, Inmaculada Calvo Penadés, et al.. (2018). Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial. The Journal of Rheumatology. 45(8). 1173–1179. 10 indexed citations

Benedetti, Fabrizio De, Hermine I. Brunner, Nicolino Ruperto, et al.. (2014). Catch‐Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial. Arthritis & Rheumatology. 67(3). 840–848. 49 indexed citations

Backeljauw, Philippe, Joyce Kuntze, James W. Frane, Ali S. Çalıkoğlu, & Steven D. Chernausek. (2013). Adult and Near-Adult Height in Patients with Severe Insulin-Like Growth Factor-I Deficiency after Long-Term Therapy with Recombinant Human Insulin-Like Growth Factor-I. Hormone Research in Paediatrics. 80(1). 47–56. 34 indexed citations

Frane, James W., George M. Bright, & Peter A. Lee. (2012). A method to determine the likelihood of transition to puberty in a heterogeneous prepubertal age group. Journal of Pediatric Endocrinology and Metabolism. 25(9-10). 843–6. 2 indexed citations

Maneatis, Thomas, et al.. (2011). Intracranial hypertension in pediatric patients treated with recombinant human growth hormone: data from 25 years of the Genentech National Cooperative Growth Study. Journal of Pediatric Endocrinology and Metabolism. 24(9-10). 627–31. 14 indexed citations

Mahan, John D., Bradley A. Warady, James W. Frane, et al.. (2010). First-year response to rhGH therapy in children with CKD: a National Cooperative Growth Study Report. Pediatric Nephrology. 25(6). 1125–1130. 13 indexed citations

Midyett, L. Kurt, et al.. (2009). Recombinant Insulin-Like Growth Factor (IGF)-I Treatment in Short Children with Low IGF-I Levels: First-Year Results from a Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 95(2). 611–619. 53 indexed citations

Alter, Craig A., et al.. (2009). A Stepwise Increase in Recombinant Human Growth Hormone Dosing During Puberty Achieves Improved Pubertal Growth: A National Cooperative Growth Study Report. Journal of Pediatric Endocrinology and Metabolism. 22(7). 623–8. 6 indexed citations

Frane, James W., et al.. (2000). Body mass index (BMI) in Turner syndrome before and during growth hormone (GH) therapy. International Journal of Obesity. 24(2). 232–235. 21 indexed citations

10.

Chernausek, Steven D., Kenneth M. Attie, José Cara, Ron G. Rosenfeld, & James W. Frane. (2000). Growth Hormone Therapy of Turner Syndrome: The Impact of Age of Estrogen Replacement on Final Height¹. The Journal of Clinical Endocrinology & Metabolism. 85(7). 2439–2445. 80 indexed citations

11.

Powell, D.R., Susan K. Durham, Eileen D. Brewer, et al.. (1999). Effects of Chronic Renal Failure and Growth Hormone on Serum Levels of Insulin-Like Growth Factor-Binding Protein-4 (IGFBP-4) and IGFBP-5 in Children: A Report of the Southwest Pediatric Nephrology Study Group¹². The Journal of Clinical Endocrinology & Metabolism. 84(2). 596–601. 34 indexed citations

12.

Rosenfeld, Ron G., Kenneth M. Attie, James W. Frane, et al.. (1998). Growth hormone therapy of Turner's syndrome: Beneficial effect on adult height. The Journal of Pediatrics. 132(2). 319–324. 194 indexed citations

13.

Bott, R. & James W. Frane. (1990). Incorporation of crystallographic temperature factors in the statistical analysis of protein tertiary structures. Protein Engineering Design and Selection. 3(8). 649–657. 15 indexed citations

14.

August, Gilbert P., Barbara M. Lippe, Sandra L. Blethen, et al.. (1990). Growth hormone treatment in the United States: Demographic and diagnostic features of 2331 children. The Journal of Pediatrics. 116(6). 899–903. 90 indexed citations

15.

Rosenfeld, Ron G., Raymond L. Hintz, Ann J. Johanson, et al.. (1988). Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. The Journal of Pediatrics. 113(2). 393–400. 91 indexed citations

16.

Hintz, Raymond L., et al.. (1988). Treatment of Turner's Syndrome with Recombinant Human Growth Hormone (Somatrem). Acta Paediatrica. 77(s343). 47–52. 7 indexed citations

17.

Moore, Jerome A., et al.. (1988). Equivalent Potency and Pharmacokinetics of Recombinant Human Growth Hormones with or without an N-Terminal Methionine. Endocrinology. 122(6). 2920–2926. 24 indexed citations

18.

Wilson, Darrell M., James W. Frane, Barry M. Sherman, et al.. (1988). Carbohydrate and lipid metabolism in Turner syndrome: Effect of therapy with growth hormone, oxandrolone, and a combination of both. The Journal of Pediatrics. 112(2). 210–217. 80 indexed citations

19.

Rosenfeld, Ron G., Raymond L. Hintz, A Johanson, et al.. (1986). Methionyl human growth hormone and oxandrolone in Turner syndrome: Preliminary results of a prospective randomized trial. The Journal of Pediatrics. 109(6). 936–943. 62 indexed citations

20.

Frane, James W.. (1980). Some computing methods for unbalanced analysis of variance and covariance. Communication in Statistics- Theory and Methods. 9(2). 151–166. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact